Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:sodium_oxybate
|
| gptkbp:approvalYear |
2002
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
N07XX04
|
| gptkbp:chemicalClass |
oxybates
|
| gptkbp:contraindication |
concurrent use with sedative hypnotics
succinic semialdehyde dehydrogenase deficiency |
| gptkbp:form |
oral solution
|
| gptkbp:halfLife |
0.5 to 1 hour
|
| gptkbp:legalStatus |
gptkb:Schedule_III_controlled_substance_(US)
prescription only |
| gptkbp:manufacturer |
gptkb:Jazz_Pharmaceuticals
|
| gptkbp:otherName |
gptkb:sodium_oxybate
gamma-hydroxybutyric acid sodium salt |
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:riskFactor |
respiratory depression
potential for abuse CNS depression |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
confusion
nausea dizziness headache enuresis |
| gptkbp:usedFor |
narcolepsy
excessive daytime sleepiness cataplexy |
| gptkbp:bfsParent |
gptkb:Jazz_Pharmaceuticals
gptkb:Sodium_oxybate |
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Xyrem
|